In the modern clinical environment, the Luer connector serves as the critical interface for fluid transfer, patient monitoring, and drug delivery. As a leading China Luer connector manufacturer, we recognize that this industry is currently undergoing its most significant regulatory shift in decades—the transition from ISO 594 to ISO 80369-7. This change isn't merely administrative; it's a profound engineering evolution designed to eliminate fatal misconnection errors.
The global demand for Luer-based systems is no longer just about "the connector." It's about Security of Supply and Material Biocompatibility. Procurement officers from Europe and North America are increasingly auditing factories for "Extractables and Leachables (E&L)" profiles, ensuring that the plasticizers used do not interact with advanced biologics or chemotherapy drugs.
Implementation of ISO 80369 series design to prevent accidental connections between enteral, neuraxial, and intravascular lines.
Utilizing 100% virgin medical-grade polymers, free from BPA, Latex, and DEHP, ensuring patient safety in long-term IV therapy.
Multi-cavity high-speed injection systems with tolerance controls within ±0.01mm for leak-proof performance.
Global healthcare procurement is shifting from "lowest unit cost" to "Total Cost of Ownership (TCO)." For a Luer connector factory, this means providing more than just a component. It involves comprehensive supply chain integration. We assist global enterprises in solving the three major macro challenges:
The next five years will see the rise of "Smart Connectors"—Luer systems integrated with RFID or NFC for medication tracking and patient safety. Furthermore, the miniaturization of drug delivery devices requires Micro-Luer connectors with even tighter tolerances. JZCare is already investing in R&D for silicone-free lubricants and laser-welding technologies to replace traditional bonding agents, eliminating chemical risks.
Hangzhou JZCare Medical Co., Ltd. is a professional medical consumables manufacturer specializing in disposable medical syringes, sterile injection devices, and high-quality healthcare disposable products for global medical markets. Established in 2011 and located in Hangzhou, China, the company integrates research and development, precision injection molding, automated production, sterilization processing, and global OEM/ODM services.
JZCare operates a modern manufacturing facility covering approximately 26,000 square meters with more than 300 employees, including experienced engineers, quality inspectors, and production specialists. The factory is equipped with advanced cleanroom workshops, fully automated assembly lines, and strict quality control systems to ensure product safety, consistency, and compliance with international medical standards. Annual production capacity exceeds 1.5 billion units of disposable medical products, supplying hospitals, clinics, laboratories, and healthcare distributors worldwide.
The company’s core product range includes disposable syringes, hypodermic syringes, safety syringes, insulin syringes, luer lock and luer slip syringes, and various sterile medical injection consumables. By adopting high-precision manufacturing technology, medical-grade materials, and rigorous sterilization processes, JZCare ensures reliable performance and patient safety in every product.
Driven by continuous innovation and global healthcare demand, Hangzhou JZCare Medical Co., Ltd. is committed to providing safe, efficient, and cost-effective medical disposable solutions while maintaining strong partnerships with international clients through stable quality, flexible customization, and professional service support.
JZCare Syringe
